Table 1.
Baseline characteristics of intervention and control group participants (N = 1235).
| Control group | Intervention group |
p-value* | |
|---|---|---|---|
| n (%) | n (%) | ||
| 655 | 580 | ||
| Demographic characteristics | |||
| Age at diagnosis (categories) | |||
| <50 years | 183 (27.9) | 182 (31.4) | 0.331 |
| 51–65 years | 362 (55.3) | 300 (51.7) | |
| >65 years | 110 (16.8) | 98 (16.9) | |
| Race/ethnicity | |||
| Non Latina White | 229 (35.0) | 202 (34.8) | 0.877 |
| Latina | 144 (22.0) | 141 (24.3) | |
| Black or African American | 150 (22.9) | 125 (21.6) | |
| Asian or Pacific Islander | 123 (18.8) | 105 (18.1) | |
| Native American or Other | 9 (1.4) | 7 (1.2) | |
| Marital status | |||
| Married/living with a partner | 288 (44.3) | 261 (45.2) | 0.802 |
| Education | |||
| High school diploma or less | 216 (33.3) | 175 (30.4) | 0.200 |
| Some college | 155 (23.9) | 167 (29.1) | |
| College degree and higher | 278 (42.8) | 233 (40.5) | |
| Language of interview | |||
| English | 572 (87.3) | 507 (87.4) | 0.944 |
| Spanish or Chinese | 83 (12.7) | 73 (12.6) | |
| Health characteristics | |||
| Clinic site | |||
| Site 1 | 435 (66.4) | 411 (70.9) | 0.135 |
| Site 2 | 220 (33.6) | 169 (29.1) | |
| Health insurance | |||
| Any private insurance | 291 (44.4) | 297 (51.2) | 0.022 |
| Only public insurance | 350 (53.4) | 265 (45.7) | |
| No insurance | 14 (2.1) | 18 (3.1) | |
| Primary care visits during last year | |||
| 0 to 1 | 176 (27.2) | 164 (28.6) | 0.097 |
| 2 to 3 | 211 (32.5) | 214 (37.4) | |
| 4+ | 261 (40.3) | 195 (34.0) | |
| Comorbid conditions | |||
| 0 | 45 (6.9) | 39 (6.7) | 0.979 |
| 1 to 2 | 256 (39.1) | 226 (39.0) | |
| 3+ | 354 (54.1) | 315 (54.3) | |
| Perception of health status | |||
| Excellent/very good | 211 (32.4) | 203 (35.2) | 0.399 |
| Good/fair/poor | 441 (67.6) | 373 (64.8) | |
| Assessment of risk for breast cancer | |||
| Risk category for breast cancer | |||
| Average risk, no relatives with BC | 410 (62.6) | 338 (58.3) | 0.097 |
| Average risk, + relatives with BC | 99 (15.1) | 81 (14.0) | |
| High risk, BCSC/Gail | 97 (14.8) | 101 (17.4) | |
| High risk, RST ≥2 | 49 (7.5) | 60 (10.3) | |
Boldface indicates statistical significance (p < 0.05).
*
P-values from GEE analyses accounting for clustering of observations by physician.